roche deal, page-10

On current projects underway, i think we should here something on Mediimune/AstraZeneca collaboration in the near future most recent guidance on it was screening anticipated to be complete by mid year. Also for future partnerships it would be good to see the collaboration with Isogenica put in motion as it rapidly accelerated the screening process allowing lead candidates to be identified in significantly shorter time frames.

If PYC could accelerate their inital role by screening the libraries in 3-6 months as opposed to the current format of 9-12 months it would free up lab space & allow multiple projects to be put in motion without significantly increasing both staff & labratory size. The more partnerships that can be initiated & then completed on Phylogicas end just means more that are then open to benefit with no further work or expenditure required. It's just building a warchest of potential milestones payments & royalties.

Until one finds it more in their interest to take it out